Kimberly-Clark closes its acquisition of Tylenol maker Kenvue. What to expect next

Kimberly-Clark has a plan improve growth and earnings following its acquisition of Kenvue

Summary from the CNBC news feed. Copyright belongs to CNBC.

Opens in a new tab, so Investz stays open.

ShareEmail X LinkedIn Facebook Reddit WhatsApp

More headlines

CNBCSupreme Court rejects DOJ's bid to block California from counting disputed ballots CNBCStocks making the biggest moves after hours: Fabrinet, Clorox, Apple, Palantir & more CNBCStock market after midterm elections: What S&P 500 history shows CNBCApple's stock drops on weak margin forecast in Ternus’ first earnings report: Live updates CNBCPalantir reports booming U.S. commercial revenue growth, topping government for first time CNBCFeeling isolated? Half of in-office workers describe their desk jobs as 'remote,' NY Fed survey finds

Headlines and summaries come from publishers’ public news feeds and are shown with attribution and a link to the original. Investz does not write or endorse them and they are not investment advice. Disclosures.